Open AccessTreatment of immune checkpoint inhibitor-induced inflammatory arthritis
Author(s) -
Susanna Jeurling,
Laura C. Cappelli
Publication year - 2020
Publication title -
current opinion in rheumatology/current opinion in rheumatology, with evaluated medline
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.452
H-Index - 112
eISSN - 1080-8175
pISSN - 1040-8711
DOI - 10.1097/bor.0000000000000701
Subject(s) - medicine , inflammatory arthritis , rheumatoid arthritis , arthritis , discontinuation , combination therapy , adverse effect , cancer , immunosuppression , immunology , oncology
This review summarizes the current evidence on treatment strategies for inflammatory arthritis because of cancer treatment with immune checkpoint inhibitors (ICI), prognosis of ICI-induced arthritis, and management of patients with preexisting inflammatory arthritis receiving ICI therapy.